title: Comparison between one and three years of treatment in uncomplicated childhood epilepsy: a prospective study. I. Outcome in different seizure types.
abstract: OBJECTIVE
  The main purpose of this prospective study was to analyze whether 1 year of treatment was as effective as 3 years with respect to remission rate in children with idiopathic epilepsy.
  
  
  METHODS
  Treatment for epileptic seizures was started in 207 children aged 2-16 years. They were randomized to treatment for 1 or 3 years. At the end of the predetermined treatment period, 161 children had been seizure-free for 6 months and the treatment could be gradually withdrawn.
  
  
  RESULTS
  The overall remission rate in our group of patients was significantly higher (71%) in the group treated for 3 years than in the group treated for 1 year (53%). However, comparison of remission rates between patients with different seizure types showed statistically significant differences in outcome depending on duration of treatment only in children with complex partial seizures (CPS).
  
  
  CONCLUSIONS
  Our results show that 1 year of treatment can be recommended in children with benign partial epilepsy with rolandic spikes (BECT) and in children with simple partial seizures (SPS) but is clearly insufficient in children with CPS. A proper seizure classification is one important tool, although not sufficient, in offering recommendations concerning the duration of treatment in children with idiopathic epilepsy.
authors.affiliation: Department of Pediatrics, Karolinska Institute, Huddinge University Hospital, Sweden.
authors.forename: G
authors.initials: G
authors.lastname: Braathen
authors.forename: T
authors.initials: T
authors.lastname: Andersson
authors.forename: H
authors.initials: H
authors.lastname: Gylje
authors.forename: H
authors.initials: H
authors.lastname: Melander
authors.forename: A S
authors.initials: AS
authors.lastname: Naglo
authors.forename: L
authors.initials: L
authors.lastname: Norén
authors.forename: A
authors.initials: A
authors.lastname: Persson
authors.forename: A
authors.initials: A
authors.lastname: Rane
authors.forename: K
authors.initials: K
authors.lastname: Sjörs
authors.forename: K
authors.initials: K
authors.lastname: Theorell
authors.forename: A
authors.initials: A
authors.lastname: Wigertz
mesh_terms: D000293:Adolescent; D000927:Anticonvulsants / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004828:Epilepsies, Partial / Q000188:drug therapy; D004827:Epilepsy / Q000188:drug therapy*; D017029:Epilepsy, Complex Partial / Q000188:drug therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D011379:Prognosis; D011446:Prospective Studies; D012008:Recurrence; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000927:Anticonvulsants